Notices. Notice of application
283 words·~1 min read·
/register/2020/02/03/2020-01959·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-576] Bulk Manufacturer of Controlled Substances Application: Noramco Inc. ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 3, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention:
DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 17, 2019, Noramco Inc., 1550 Olympic Drive, Athens, Georgia 30601 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Schedule Cathinone 1235 I Gamma Hydroxybutyric Acid 2010 I Marihuana Extract 7350 I Marihuana 7360 I Tetrahydrocannabinols 7370 I Codeine-N-oxide 9053 I Dihydromorphine 9145 I Hydromorphinol 9301 I Morphine-N-oxide 9307 I Normorphine 9313 I Amphetamine 1100 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Nabilone 7379 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Hydrocodone 9193 II Levorphanol 9220 II Morphine 9300 II Oripavine 9330 II Thebaine 9333 II Oxymorphone 9652 II Noroxymorphone 9668 II Alfentanil 9737 II Sufentanil 9740 II Carfentanil 9743 II Tapentadol 9780 II Fentanyl 9801 II The company plans to manufacture bulk active pharmaceutical ingredients
(APIs)and reference standards for distribution to their customers. In reference to drug codes 7350 (marihuana extract), 7360 (marihuana), and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drugs are authorized for this registration. Dated: January 24, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020-01959 Filed 1-31-20; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources